Gabapentinoids (gabapentin, pregabalin) are medications primarily used to treat neuropathic pain, epilepsy, and sometimes anxiety or restless legs syndrome.
They function by binding to voltage-gated calcium channels, reducing neurotransmitter release, and stabilizing neuronal excitability.
Gabapentinoids are a class of medications structurally related to the neurotransmitter GABA, primarily including gabapentin and pregabalin.
They bind to the α2δ subunit of voltage-gated calcium channels, reducing neurotransmitter release like glutamate to help manage certain neurological conditions.
Common side effects include dizziness, fatigue, and weight gain, with growing concern regarding misuse potential.
Key Gabapentinoids Gabapentin (Neurontin, Gralise, Horizant): Used for postherpetic neuralgia and seizures. Pregabalin (Lyrica): Used for neuropathic pain, fibromyalgia, and seizures. Mirogabalin (Tarlige): Used for neuropathic pain.
subunit of voltage-gated calcium channels. By binding to this subunit, they reduce the influx of calcium into neurons, thereby decreasing the release of excitatory neurotransmitters (e.g., glutamate).
Uses
These drugs treat epilepsy as adjunctive therapy, neuropathic pain from diabetic neuropathy or postherpetic neuralgia, fibromyalgia, and restless legs syndrome.
Off-label applications often include insomnia, anxiety disorders, migraine, bipolar disorder, and alcohol withdrawal. Neuropathic Pain: Often first-line treatment for conditions like postherpetic neuralgia. Epilepsy: Adjunctive therapy for partial-onset seizures. Other Potential Uses: Fibromyalgia, anxiety, restless leg syndrome and alcohol withdrawal.
Side Effects and Risks Common: Dizziness, somnolence, peripheral edema, ataxia, and weight gain.
Serious: Potential respiratory depression, especially if combined with opioids, suicidal thoughts, and dependence.
Abrupt cessation can cause withdrawal symptoms including anxiety, tachycardia, and tremor.
Misuse: Increased recognition of abuse potential, particularly in individuals with a history of opioid abuse.
Administration and Dosage Gabapentinoids are typically started at low doses and titrated upward to manage side effects, with dosages commonly ranging between 900 mg to 3,600 mg daily for gabapentin.
They are primarily cleared by the kidneys, necessitating dose adjustments in patients with renal impairment.
Gabapentinoids do not directly mimic GABA or bind GABA receptors but inhibit calcium influx at synapses, decreasing excitatory signaling.
They also block α2δ-1 subunit trafficking in dorsal root ganglia, limit synapse formation via thrombospondin, and enhance glutamate uptake.
Pregabalin is about 2-3 times more potent than gabapentin, with better bioavailability and linear pharmacokinetics, while gabapentin requires dose escalation due to saturable absorption.
Both agents are renally excreted without significant metabolism or protein binding, requiring dose adjustments in kidney impairment.
Common side effects include dizziness, somnolence, and weight gain; pregabalin may carry higher misuse potential due to euphoria at high doses.